Search

everythinglearnresearchcommunity

for

Search:↓

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Blocking certain immune signals can reduce skin damage from radiation therapy.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

taVNS reduces vitiligo symptoms in mice.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Ginseng, especially its component ginsenosides, can promote hair growth, reduce hair loss, and potentially treat conditions like alopecia by affecting cell pathways and cytokines.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

A patient with complete hair loss regrew all her hair using tofacitinib.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.